Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

Syndax Pharmaceuticals (SNDX) Return on Capital Employed: 2016-2020

Historic Return on Capital Employed for Syndax Pharmaceuticals (SNDX) over the last 5 years, with Dec 2020 value amounting to -0.32%.

  • Syndax Pharmaceuticals' Return on Capital Employed rose 79.00% to -0.32% in Q4 2020 from the same period last year, while for Dec 2020 it was -0.32%, marking a year-over-year increase of 79.00%. This contributed to the annual value of -0.60% for FY2024, which is 14.00% down from last year.
  • Per Syndax Pharmaceuticals' latest filing, its Return on Capital Employed stood at -0.32% for Q4 2020, which was up 16.10% from -0.39% recorded in Q3 2020.
  • Syndax Pharmaceuticals' 5-year Return on Capital Employed high stood at -0.22% for Q2 2016, and its period low was -1.12% during Q4 2019.
  • Its 3-year average for Return on Capital Employed is -0.77%, with a median of -0.88% in 2019.
  • As far as peak fluctuations go, Syndax Pharmaceuticals' Return on Capital Employed plummeted by 49bps in 2018, and later spiked by 79bps in 2020.
  • Quarterly analysis of 5 years shows Syndax Pharmaceuticals' Return on Capital Employed stood at -0.42% in 2016, then decreased by 11bps to -0.54% in 2017, then tumbled by 49bps to -1.02% in 2018, then decreased by 9bps to -1.12% in 2019, then spiked by 79bps to -0.32% in 2020.
  • Its Return on Capital Employed was -0.32% in Q4 2020, compared to -0.39% in Q3 2020 and -0.43% in Q2 2020.